Skip to main navigation Skip to search Skip to main content

A multicenter, randomized, double-blind, parallel group study to assess the safety and tolerability of initiating LCZ696 in heart failure patients comparing two titration regimens

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/13 → 08/31/15

Funding

  • Novartis Pharmaceuticals Corporation: $9,556.35